DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 130 filers reported holding DENALI THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 258.00 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $46,870,359 | +1559.7% | 2,018,534 | +1366.7% | 0.02% | +1500.0% |
| Q1 2024 | $2,823,962 | -6.0% | 137,620 | -1.7% | 0.00% | 0.0% |
| Q4 2023 | $3,003,542 | +6.5% | 139,960 | +2.3% | 0.00% | 0.0% |
| Q3 2023 | $2,821,359 | -46.5% | 136,760 | -23.5% | 0.00% | -50.0% |
| Q2 2023 | $5,274,027 | +34.5% | 178,720 | +5.0% | 0.00% | 0.0% |
| Q1 2023 | $3,920,486 | -9.0% | 170,160 | +9.8% | 0.00% | 0.0% |
| Q4 2022 | $4,309,438 | -9.4% | 154,960 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $4,756,000 | +4.3% | 154,960 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $4,560,000 | -8.5% | 154,960 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $4,985,000 | -27.7% | 154,960 | +0.2% | 0.00% | 0.0% |
| Q4 2021 | $6,898,000 | -11.6% | 154,660 | 0.0% | 0.00% | -33.3% |
| Q3 2021 | $7,803,000 | -36.0% | 154,660 | -0.5% | 0.00% | -40.0% |
| Q2 2021 | $12,186,000 | +120.9% | 155,360 | +60.8% | 0.01% | +150.0% |
| Q1 2021 | $5,516,000 | -31.3% | 96,600 | +0.7% | 0.00% | -50.0% |
| Q4 2020 | $8,033,000 | +140.6% | 95,900 | +2.9% | 0.00% | +100.0% |
| Q3 2020 | $3,339,000 | +44.7% | 93,200 | -2.3% | 0.00% | +100.0% |
| Q2 2020 | $2,307,000 | +84.6% | 95,400 | +33.6% | 0.00% | 0.0% |
| Q1 2020 | $1,250,000 | +1.1% | 71,400 | +0.6% | 0.00% | 0.0% |
| Q4 2019 | $1,237,000 | +13.7% | 71,000 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $1,088,000 | -26.2% | 71,000 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $1,474,000 | -8.5% | 71,000 | +2.3% | 0.00% | 0.0% |
| Q1 2019 | $1,611,000 | +12.3% | 69,400 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $1,434,000 | +25.9% | 69,400 | +32.4% | 0.00% | 0.0% |
| Q3 2018 | $1,139,000 | +194.3% | 52,400 | +106.3% | 0.00% | – |
| Q2 2018 | $387,000 | – | 25,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Crestline Management, LP | 7,705,039 | $343,645,000 | 25.68% |
| Casdin Capital, LLC | 1,500,000 | $66,900,000 | 1.89% |
| Flagship Pioneering Inc. | 2,619,968 | $116,851,000 | 1.81% |
| SECTORAL ASSET MANAGEMENT INC | 189,600 | $8,456,000 | 1.27% |
| Integral Health Asset Management, LLC | 100,000 | $4,460,000 | 1.23% |
| Temasek Holdings (Private) Ltd | 5,369,487 | $239,479,000 | 0.86% |
| Goldstream Capital Management Ltd | 78,418 | $3,497,000 | 0.86% |
| Yiheng Capital Management, L.P. | 335,184 | $14,949,000 | 0.76% |
| GILDER GAGNON HOWE & CO LLC | 2,900,114 | $129,345,000 | 0.74% |
| Artal Group S.A. | 600,000 | $26,760,000 | 0.73% |